Pharmaceutical Technology\'s In the Lab eNewsletter-01-08-2020

There is intense focus on the prevention and control of viral contaminants during viral vector manufacturing, which is driving the need for more accurate and powerful analytical methods for detection.

Drug companies will have to sharpen their understanding of evolving E&L regulatory expectations in order to remain compliant.

The Ireland-based company can now offer complete elemental impurities testing services.

The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.

The device uses the air permeability technique to enhance the productivity and accuracy of particle sizing.

The board consists of industry thought leaders who will work to develop new service offerings for the company.

The Biosero Acceleration Lab in San Diego, CA, opened its doors to executives, managers, researchers, and automation engineers to showcase its flagship Green Button Go Automation Scheduling Software.

The company was recognized in the Technology Innovation category, which acknowledges products and services that use technology solutions to serve the industry and promote innovations.

Sartorius and the German Research Center for Artificial Intelligence have established a research laboratory for AI in the biopharmaceutical industry.

Through the collaboration, Charles River plans to expand its suite of authentic human cells by utilizing Bit Bio’s target discovery, validation, and screening services to further the development of therapies with a higher chance of success in patients.

GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) are partnering on 3D-printing of tissues that can be used for discovery and cytotoxicity testing.

The new Technology Excellence Center, located in Boston, MA, will further the company’s presence in the United States biopharma drug development landscape.